Accretion Nutraveda IPO
Accretion Nutraveda IPO
Overview
Accretion Nutraveda IPO is a book build issue of ₹24.77 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹24.77 crore. Accretion Nutraveda IPO opens for subscription on Jan 27, 2026 and closes on Jan 30, 2026. The allotment for the Accretion Nutraveda IPO is expected to be finalized on Feb 2, 2026. Accretion Nutraveda IPO will list on BSE SME with a tentative listing date fixed as Feb 4, 2026. Accretion Nutraveda IPO price band is set at ₹122 to ₹129 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,58,000 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹3,87,000. Sobhagya Capital Options Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Issue Size
₹19,20,000
Issue Price
₹25 Cr
Price Band
₹122 – ₹129
Lot Size
1000 shares
Min. Investment
₹1,22,000
Max. Investment
₹1,29,000
Open Date
28 Jan, 2026
Close Date
30 Jan, 2026
Allotment
02 Feb, 2026
Listing
04 Feb, 2026
Max. Investment
₹1,29,000
Announced
28 Jan, 2026
Opening Date
28 Jan, 2026
Closing Date
30 Jan, 2026
Basis of Allotment
02 Feb, 2026
Initiation of Refunds
03 Feb, 2026
Credit of Shares
03 Feb, 2026
Listing Date
04 Feb, 2026
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Accretion Nutraveda IPO
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurv
Accretion Nutraveda IPO Share Price
Issue Breakdown
Shareholding
Dilution: 36.1% increase in shares
Accretion Nutraveda IPO Financial Health
Accretion Nutraveda Ltd.'s revenue increased by 209% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
Accretion Nutraveda IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2000 | ₹2,58,000 |
| Individual investors (Retail) (Max) | 2 | 2000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 7000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 8000 | ₹10,32,000 |
(All values in CR)
Accretion Nutraveda IPO Valuations
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Metric | Value |
|---|---|
| ROE | 81.22 |
| ROCE | 36.98 |
| Debt/Equity | 0.72 |
| RoNW | 48.85 |
| PAT Margin | 16.33 |
| EBITDA Margin | 22.79 |
| Price to Book Value | 8.76 |
(All values in CR)
Accretion Nutraveda IPO Strength & Risk
Strengths of Accretion Nutraveda IPO
• Operates in nutraceuticals and Ayurvedic manufacturing with growing market demand
• Provides contract manufacturing services across tablets, capsules, liquids and powders
• Reported revenue growth with improving profitability in recent financials
• Healthy margins and return ratios indicate operational efficiency
• Diversified product portfolio supports multiple customer segments
• SME listing provides access to capital for expansion and visibility
Risks of Accretion Nutraveda IPO
• SME IPOs generally face lower liquidity and higher price volatility
• Raw material price fluctuations may impact margins
• Faces competition from larger nutraceutical and pharma manufacturers
• Business sensitive to regulatory changes in health and wellness sectors
• Execution risk while scaling operations and expanding capacity
Accretion Nutraveda IPO Subscriptions Status
Accretion Nutraveda IPO subscribed 0.16 times. The public issue subscribed 0.24 times in the individual investors category, 0.00 times in QIB (Ex Anchor), and 0.17 times in the NII category by January 29, 2026 10:59:56 AM (Day 2).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 5,44,000 | 5,44,000 | 7.018 |
| Market Maker | 1.00 | 96,000 | 96,000 | 1.238 |
| QIB (Ex Anchor) | 0.00 | 3,64,000 | 0 | 0 |
| NII | 0.17 | 2,76,000 | 48,000 | 0.619 |
| bNII (> ₹10L) | 0.26 | 1,84,000 | 48,000 | 0.619 |
| sNII (< ₹10L) | 0.39 | 92,000 | 36,000 | 0.464 |
| Individual Investors | 0.24 | 6,40,000 | 1,54,000 | 1.987 |
| Total | 0.16 | 12,80,000 | 2,02,000 | 2.606 |
Accretion Nutraveda IPO GMP
Accretion Nutraveda SME IPO last GMP is ₹0, last updated Jan 29th 2026 10:02 AM. With the price band of 129.00, Accretion Nutraveda SME IPO's estimated listing price is ₹129 (cap price + today's GMP).The expected percentage gain/loss per share is 0.00%.
Last updated 29 Jan, 2026 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 29 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 29 Jan, 2026 |
| 28 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 28 Jan, 2026 |
| 27 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 27 Jan, 2026 |
| 26 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 26 Jan, 2026 |
| 25 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 25 Jan, 2026 |
| 24 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 24 Jan, 2026 |
| 23 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 23 Jan, 2026 |
| 22 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 22 Jan, 2026 |
| 21 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 21 Jan, 2026 |
| 20 Jan, 2026 | 129 | ₹0 | - | ₹129 (0.00%) | - | 20 Jan, 2026 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Accretion Nutraveda IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Accretion Nutraveda IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.